This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Use of 'Merck' violated agreement, prior UK court order, panel affirms

By Melissa Ritti ( March 28, 2025, 16:03 GMT | Insight) -- An appellate court in the UK refused today to undo findings that continued use by Merck & Co. and Merck Sharp & Dohme of “Merck” online in the UK ran afoul of not only its promise to Germany’s Merck KGaA but also a 2021 final order by the UK High Court. Both sides trace their origins to the same Darmstadt, Germany, family apothecary founded in 1668 — but their businesses have been separated for over 100 years.The UK Court of Appeal left intact, today, a UK High Court judge’s determination that Merck & Co. and its subsidiary, Merck Sharp & Dohme, or MSD, wrongly referred to themselves as “Merck” online in the UK....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections